[{"id":"6d090250-4edb-49a5-96dd-dfb40834e905","acronym":"","url":"https://clinicaltrials.gov/study/NCT05127135","created_at":"2021-11-19T12:53:35.559Z","updated_at":"2024-07-02T16:36:20.442Z","phase":"Phase 1","brief_title":"Safety and Efficacy of ThisCART7 in Patients With Refractory or Relapsed T Cell Malignancies","source_id_and_acronym":"NCT05127135","lead_sponsor":"Fundamenta Therapeutics, Ltd.","biomarkers":" CD7","pipe":"","alterations":" ","tags":["CD7"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ThisCART7"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 01/22/2020","start_date":" 01/22/2020","primary_txt":" Primary completion: 01/24/2023","primary_completion_date":" 01/24/2023","study_txt":" Completion: 12/24/2023","study_completion_date":" 12/24/2023","last_update_posted":"2021-11-19"}]